Literature DB >> 23627997

Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery.

Antonella Galeone1, Crescenzia Rotunno, Pietro Guida, Assunta Bisceglie, Giovanni Rubino, Luigi de Luca Tupputi Schinosa, Domenico Paparella.   

Abstract

OBJECTIVES: To assess the incidence of incomplete heparin reversal and heparin rebound after cardiac surgery with cardiopulmonary bypass (CPB) and the ability of the activated coagulation time (ACT) and thromboelastography (TEG) to detect these phenomena.
DESIGN: Prospective single-center study.
SETTING: University hospital. PARTICIPANTS: Forty-one patients undergoing elective cardiac surgery with CPB and with normal preoperative TEG parameters.
INTERVENTIONS: ACT, TEG, and plasma heparin levels were measured in all patients at 5 different times between 20 minutes and 3 hours after protamine administration. The variability of TEG reaction time (R) with and without heparinase (delta-R [DR]) was used to detect the presence of residual heparin.
MEASUREMENTS AND MAIN RESULTS: Plasma heparin expressed as anti-FXa activity was detected in 180 (88%) samples. At univariate analysis, ACT, R-kaolin (R-k), and DR significantly correlated with plasma heparin concentration (respectively, p = 0.007, p = 0.006, and p = 0.002). At multivariate analysis, R-k and DR remained associated with plasma heparin concentration (respectively, p = 0.014 and p = 0.004). Greater quartiles of heparin were associated with higher values of R-k and DR. Combined procedures had significantly lower DR than isolated procedures (p = 0.017), and CPB time and heparinization time positively correlated with R-k (respectively, p = 0.044 and p = 0.022). No association was observed between heparin concentration, ACT, and TEG parameters with postoperative bleeding and need for blood and blood components transfusions.
CONCLUSIONS: Heparin rebound and incomplete heparin reversal are very common phenomena after cardiac surgery with CPB; ACT is not able to detect residual heparin activity, whereas TEG analysis with and without heparinase allows the diagnosis of heparin rebound.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  activated coagulation time; cardiopulmonary bypass; heparin; heparin rebound; protamine; thromboelastography

Mesh:

Substances:

Year:  2013        PMID: 23627997     DOI: 10.1053/j.jvca.2012.10.020

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  10 in total

1.  A portable blood plasma clot micro-elastometry device based on resonant acoustic spectroscopy.

Authors:  C R Krebs; Ling Li; Alisa S Wolberg; Amy L Oldenburg
Journal:  Rev Sci Instrum       Date:  2015-07       Impact factor: 1.523

2.  TEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage.

Authors:  Kevin Fleming; Roberta E Redfern; Rebekah L March; Nathan Bobulski; Michael Kuehne; John T Chen; Michael Moront
Journal:  J Extra Corpor Technol       Date:  2017-12

3.  Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devices.

Authors:  Lisa M Baumann Kreuziger
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

4.  Endogenous Heparin-Like Substances May Cause Coagulopathy in a Patient with Severe Postpartum Hemorrhage.

Authors:  Shichun Wang; Chao Qi; Zhicheng Liu; Ting Xu; Chunyan Yao
Journal:  Transfus Med Hemother       Date:  2019-12-05       Impact factor: 3.747

Review 5.  Anticoagulation Monitoring for Perioperative Physicians.

Authors:  Cheryl L Maier; Roman M Sniecinski
Journal:  Anesthesiology       Date:  2021-10-01       Impact factor: 8.986

6.  STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass.

Authors:  Linda Shore-Lesserson; Robert A Baker; Victor Ferraris; Philip E Greilich; David Fitzgerald; Philip Roman; John Hammon
Journal:  J Extra Corpor Technol       Date:  2018-03

7.  Heparin and Protamine Titration Does Not Improve Haemostasis after Cardiac Surgery: A Prospective Randomized Study.

Authors:  Vladimir Radulovic; Anna Laffin; Kenny M Hansson; Erika Backlund; Fariba Baghaei; Anders Jeppsson
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

8.  Activated coagulation time vs. intrinsically activated modified rotational thromboelastometry in assessment of hemostatic disturbances and blood loss after protamine administration in elective cardiac surgery: analysis from the clinical trial (NCT01281397).

Authors:  Mate Petricevic; Bojan Biocina; Davor Milicic; Lucija Svetina; Marko Boban; Ante Lekić; Sanja Konosic; Milan Milosevic; Hrvoje Gasparovic
Journal:  J Cardiothorac Surg       Date:  2014-09-17       Impact factor: 1.637

9.  ACT Values after Neutralization Lower than Pre-heparinization ACT Leads to Lower Operative Times, Bleeding, and Post-Operative Transfusions in CABG Patients: an Observational Study.

Authors:  Weitie Wang; Yongwang Wang; Jinshan Wang; Rihao Xu; Junwu Chai; Wei Zhou; Honglei Chen; Fenlong Xue; Xiangrong Kong; Wang Kai
Journal:  Braz J Cardiovasc Surg       Date:  2018 Nov-Dec

10.  Is There a "Blind Spot" in Point-of-Care Testing for Residual Heparin After Cardiopulmonary Bypass? A Prospective, Observational Cohort Study.

Authors:  Saskia Wand; Daniel Heise; Nadine Hillmann; Christian Bireta; Anselm Bräuer; Nicolas von Ahsen; Michael Quintel
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.